13D/13G Filings - Nextech Crossover I GP S.a r.l.

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2024-12-26
4:29 pm
Unchanged
2024-12-2013GMersana Therapeutics, Inc.
MRSN
Nextech Crossover I GP S.a r.l.12,067,246
10.400%
0
(Unchanged)
Filing
History
2024-11-14
5:47 pm
Purchase
2024-09-3013GORIC Pharmaceuticals, Inc.
ORIC
Nextech Crossover I GP S.a r.l.5,285,714
7.500%
1,000,000increase
(+23.33%)
Filing
History
2024-11-14
5:45 pm
Purchase
2024-09-3013GMersana Therapeutics, Inc.
MRSN
Nextech Crossover I GP S.a r.l.12,067,246
9.800%
5,818,403increase
(+93.11%)
Filing
History
2024-05-24
4:15 pm
Purchase
2024-05-0613GContext Therapeutics Inc.
CNTX
Nextech Crossover I GP S.a r.l.7,419,355
9.900%
7,419,355increase
(New Position)
Filing
History
2024-05-17
08:26 am
Purchase
2024-05-1413GMersana Therapeutics, Inc.
MRSN
Nextech Crossover I GP S.a r.l.6,248,843
5.100%
6,248,843increase
(New Position)
Filing
History
2023-11-02
4:15 pm
Purchase
2023-11-0113GAmbrx Biopharma Inc.
AMAM
Nextech Crossover I GP S.a r.l.3,129,300
5.000%
3,129,300increase
(New Position)
Filing
History
2023-08-21
4:16 pm
Purchase
2023-08-1113GTango Therapeutics, Inc.
TNGX
Nextech Crossover I GP S.a r.l.5,533,980
5.400%
5,533,980increase
(New Position)
Filing
History
2023-07-07
4:15 pm
Purchase
2023-06-2713GORIC Pharmaceuticals, Inc.
ORIC
Nextech Crossover I GP S.a r.l.4,285,714
7.900%
4,285,714increase
(New Position)
Filing
History